Clinical Trials in Guangzhou, Guangzhou
13 recruiting
Showing 1–13 of 13 trials
Recruiting
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche800 enrolled36 locationsNCT06862869
Recruiting
Phase 1Phase 2
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Pancreatic CancerGastric CancerNon-small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc.250 enrolled81 locationsNCT06710132
Recruiting
Phase 3
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Small Cell Lung Cancer
Akeso560 enrolled53 locationsNCT07010263
Recruiting
Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound
Contrast Enhanced UltrasoundThyroid Papillary Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University600 enrolled2 locationsNCT07357571
Recruiting
Phase 3
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
RhinoconjunctivitisRhinitis
Inmunotek S.L.736 enrolled19 locationsNCT07348302
Recruiting
Phase 3
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
Chronic Myelomonocytic Leukemia
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.170 enrolled43 locationsNCT06647862
Recruiting
Phase 2
Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.134 enrolled28 locationsNCT06897579
Recruiting
A Real-world Study of Nitric Oxide Generator and Delivery System
Pulmonary Hypertension of Newborn
Novlead Inc.10 enrolled1 locationNCT05703191
Recruiting
Not Applicable
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
Hepatocellular CarcinomaTumor ThrombusHepatic Portal Vein Tumor Invasion
Third Affiliated Hospital, Sun Yat-Sen University234 enrolled1 locationNCT05984511
Recruiting
Phase 2
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease120 enrolled1 locationNCT06739928
Recruiting
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University21 enrolled1 locationNCT06505486
Recruiting
Not Applicable
Clinical Study of PTFE Covered Stent for Treating Portal Hypertension
Portal Hypertension
Enlight Medical Technologies (Shanghai) Co., Ltd177 enrolled4 locationsNCT06117735
Recruiting
Phase 1Phase 2
Chidamide Bridging for CAR-T Therapy
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital120 enrolled13 locationsNCT05370547